Skip to main content
logo
Haleon plc (HLN)
NYSE: HLN · Real-Time Price · USD
9.19
+0.35 (3.96%)
Nov 4, 2026, 11:39 AM EST - Market open

Revenue

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Oral Health Revenue
3.57B3.46B3.31B
Vitamins, Minerals and Supplement Revenue
1.70B1.69B1.70B
Pain Relief Revenue
2.60B2.56B2.56B
Respiratory Health Revenue
1.83B1.87B2.12B
Digestive Health Revenue
986.00M987.00M1.03B
Therapeutic Skin Health and Other Revenue
463.00M460.00M510.00M
Revenue (Total)
11.15B11.03B11.23B

Revenue by Geography

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
North America Revenue
3.85B3.87B4.04B
EMEA & LatAm Revenue
4.70B4.59B4.63B
APAC Revenue (Pre-Q3 2026 Reporting)
2.61B2.57B2.56B
Revenue (Total)
11.15B11.03B11.23B

Adjusted EBIT by Geography

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
North America Adjusted Operating Profit
984.00M947.00M1.00B
EMEA & LatAm Adjusted Operating Profit
1.18B1.09B1.05B
APAC Adjusted Operating Profit
579.00M553.00M539.00M
Corporate Adjusted Operating Profit
-99.00M-64.00M-93.00M
Operating Income (Other)
-266.00M-114.00M-294.00M
Operating Income (Total)
2.38B2.41B2.21B

Key Performance Indicators

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Organic Revenue Growth
3.00%5.00%
Sales Growth due to Price
2.30%3.70%
Sales Growth due to Volume/Mix
0.70%1.30%